MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe
匹配:使远程医疗在家中提供有效且安全的癌症护理
基本信息
- 批准号:10454670
- 负责人:
- 金额:$ 123.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAmbulatory Care FacilitiesBiological ModelsCOVID-19 pandemicCancer PatientCaringChronicClinicClinical MedicineCommunicationComputerized Medical RecordCustomDataData AnalyticsData ScienceDevicesDiagnosisDimensionsDisciplineDiverse WorkforceDoseEcosystemEffectivenessElectronic Health RecordEnsureFeedbackFutureGoalsGrowthHealth ServicesHeart failureHomeIndividualInformaticsInstitute of Medicine (U.S.)InterventionIntramuscularKnowledgeLaboratoriesLinkMachine LearningMalignant NeoplasmsMedicineMetadataMethodsModelingMonitorNew JerseyNew YorkOncologyOralOutcomeOutcome MeasureOutpatientsPalliative CarePatientsPatternPersonsPhysiciansProstate Cancer therapyQuality of CareRandomizedResearchResearch DesignResearch MethodologyResearch PersonnelResourcesRiskRuralSafetyScienceSiteSystemTechniquesTestingTimeTrainingVisitWomanWorkanalytical methodasynchronous communicationbasebehavioral healthcancer carecancer therapycare deliveryclinical practicecomplex datadata streamsdesigndigitalevidence baseexperiencehealth care qualityhealth communicationhealth equityimplementation scienceindividual patientinnovationinsightinvestigator trainingmHealthmachine learning methodmalignant breast neoplasmmenmultidisciplinarynovelpandemic diseasepatient portalpersonalized carepilot trialpragmatic trialprecision oncologyprospectiverational designskillssubcutaneoussurvivorshiptelehealthtooltrial comparingtrial designvirtual visit
项目摘要
Project Summary/Abstract
The MATCHES (Making Telehealth Delivery of Cancer Care at Home Effective and Safe) Telehealth Research
Center aims to build the evidence base necessary to establish best practices for telehealth-enabled cancer
care. The overarching goal of the Center is to create a research hub that generates evidence, trains
investigators, and develops the research methods required to ignite the field of precision cancer care delivery.
Prior work demonstrates that oncology-focused telehealth can achieve favorable outcomes, but large-scale
trials have been limited to specific contexts like palliative care or survivorship. Adoption has been constrained
by restricted reimbursement. The MATCHES Center will help remediate this evidence gap by executing
prospective trials, conducting observational analyses, and training transdisciplinary researchers. Our research
theme focuses on the integration of multi-layered data from telehealth platforms, patient portals, mobile
tracking devices, and the electronic medical record to develop analytic methods that support personalized
care. We aim to develop a new paradigm in oncology—precision delivery—with the ultimate goal of matching
individual patients with the most beneficial combination of clinic-based or telehealth-supported home-setting
care at the appropriate time—all based on the totality of dynamically available data. We will accomplish this
goal by applying data science methods—including nimble trial designs and machine learning—that have had
limited application to telehealth to date. By establishing a research hub that nurtures investigators across
disciplines and provides training, tools, data, analytic methods, and venues for sharing knowledge and building
partnerships, we expect to accelerate progress in the science of care delivery. Our specific aims are 1) to
conduct impactful pragmatic trials of telehealth in oncology, 2) to analyze a large existing cache of
multidimensional observational data characterizing telehealth utilization and outcomes, 3) to train investigators
and equip them with the skills necessary to innovate within an evidence-based framework, and 4) to integrate
telehealth with other data streams and create and apply analytic methods to transform the field of precision
care delivery. An Administrative Core will coordinate activities and engage feedback from internal and external
stakeholders—including patients and the oncology workforce. Our Clinical Practice Network serves as an
innovation laboratory and comprises 7 outpatient clinics in NY and NJ with a shared informatics ecosystem
including telehealth capacity, digital monitoring, and a highly trafficked patient portal. This will enable us to
launch and execute a large pragmatic trial comparing in-person care to telehealth, with resources designed to
support home-based care using a cluster-randomized design. The Research & Methods Core will support the
Center by applying data science methods to extract and synthesize insights from telehealth and other data
streams to develop methods relevant to advancing precision cancer care delivery and the goals of equity,
efficacy, and efficiency to create an optimal experience for people being treated for cancer.
项目摘要/摘要
Matches(使远程医疗在家中提供有效和安全的癌症护理)远程医疗研究
该中心的目标是建立必要的证据基础,以建立远程医疗癌症的最佳实践
关心。该中心的首要目标是创建一个研究中心,以产生证据、培训
研究人员,并开发所需的研究方法,以点燃精确的癌症护理提供领域。
先前的工作表明,专注于肿瘤学的远程医疗可以取得良好的结果,但大规模
试验一直局限于特定的情况,如姑息治疗或生存。收养一直受到限制
通过限制报销。匹配中心将通过执行以下操作来帮助弥补这一证据差距
前瞻性试验,进行观察分析,并培训跨学科研究人员。我们的研究
主题侧重于从远程医疗平台、患者门户、移动设备
跟踪设备和电子病历,以开发支持个性化的分析方法
关心。我们的目标是开发一种新的肿瘤学范式-精确交付-最终目标是匹配
以诊所为基础的或远程医疗支持的家庭环境最有益的组合的个体患者
在适当的时间进行护理--所有这些都基于动态可用的全部数据。我们会做到这一点的
目标是应用数据科学方法-包括灵活的试验设计和机器学习-这些方法已经
到目前为止,远程医疗的应用有限。通过建立一个研究中心,培养各地的调查人员
学科,并提供培训、工具、数据、分析方法以及共享知识和构建
在伙伴关系方面,我们希望加快护理提供科学方面的进展。我们的具体目标是1)
在肿瘤学中进行远程医疗的有效实用试验,2)分析现有的大量
表征远程医疗利用和结果的多维观察数据,3)培训调查人员
并让他们掌握在循证框架内创新所需的技能,以及4)整合
与其他数据流进行远程保健,并创建和应用分析方法来转变精度领域
护理服务。行政核心将协调活动,并听取内部和外部的反馈
利益相关者-包括患者和肿瘤学工作人员。我们的临床实践网络作为
创新实验室,由纽约和新泽西州的7家门诊诊所组成,共享信息生态系统
包括远程医疗功能、数字监控和高流量的患者门户。这将使我们能够
启动并执行一项大型务实试验,将面对面护理与远程保健进行比较,其资源旨在
使用群集式随机设计支持基于家庭的护理。研究与方法核心将支持
通过应用数据科学方法从远程医疗和其他数据中提取和综合见解
开发与推进精确癌症护理提供和公平目标相关的方法,
功效和效率,为正在接受癌症治疗的人创造最佳体验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL J MORRIS其他文献
EFFECTS OF PARTICULATE MATTER INHALATION ON CHEST IMAGING DURING DEPLOYMENT TO OPERATION INHERENT RESOLVE (OIR)
- DOI:
10.1016/j.chest.2022.08.1649 - 发表时间:
2022-10-01 - 期刊:
- 影响因子:
- 作者:
TYSON J SJULIN;MICHAEL J MORRIS;SALLY DELVECCHIO;GIOVANNI LORENZ;BENJAMIN P ILIFF - 通讯作者:
BENJAMIN P ILIFF
CASE REPORT: USE OF THE SERAPH-100 BLOOD FILTER IN LINE WITH EXTRACORPOREAL MEMBRANE OXYGENATION CIRCUIT FOR TREATMENT OF SEPTIC SHOCK FROM ENTEROCOCCUS FAECALIS BACTEREMIA
病例报告:在体外膜氧合回路中使用 SERAPH-100 血液过滤器联合治疗粪肠球菌菌血症所致的感染性休克
- DOI:
10.1016/j.chest.2022.08.800 - 发表时间:
2022-10-01 - 期刊:
- 影响因子:8.600
- 作者:
STEVEN STOFFEL;JOSHUA BOSTER;HENRY DANCHI;MELISSA ROSAS;MICHAEL J MORRIS;MAI T NGUYEN;ROBERT J WALTER - 通讯作者:
ROBERT J WALTER
CHARACTERIZING THE ASTHMA PHENOTYPE OF SERVICE-CONNECTED MEDICALLY SEPARATED MILITARY PERSONNEL
- DOI:
10.1016/j.chest.2023.07.3171 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
JOSHUA BOSTER;STEVEN STOFFEL;WILLIAM MOORE;MICHAEL J MORRIS - 通讯作者:
MICHAEL J MORRIS
REPEAT PULMONARY FUNCTION TESTING IN ACTIVE DUTY MILITARY FOR PULMONARY DISEASES RELATED TO ENVIRONMENTAL DEPLOYMENT EXPOSURES (STAMPEDE III)
- DOI:
10.1016/j.chest.2022.08.1651 - 发表时间:
2022-10-01 - 期刊:
- 影响因子:
- 作者:
STEVEN STOFFEL;JESS T. ANDERSON;MATEO HOULE;ROBERT J WALTER;MICHAEL J MORRIS - 通讯作者:
MICHAEL J MORRIS
ETIOLOGIES AND CHARACTERISTICS OF INTERSTITIAL LUNG DISEASE IN AN ACTIVE-DUTY MILITARY POPULATION
- DOI:
10.1016/j.chest.2023.07.2064 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:
- 作者:
WILLIAM MOORE;JOSHUA BOSTER;MICHAEL J MORRIS;IAN CHR MCINNIS;BRIAN S BARBER;MICHAEL A GONZALES - 通讯作者:
MICHAEL A GONZALES
MICHAEL J MORRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL J MORRIS', 18)}}的其他基金
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe
匹配:使远程医疗在家中提供有效且安全的癌症护理
- 批准号:
10673980 - 财政年份:2022
- 资助金额:
$ 123.9万 - 项目类别:
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe - Addressing missing data in the MATCHES study to improve ML/AI readiness
MATCHES:使远程医疗在家中有效且安全地提供癌症护理 - 解决 MATCHES 研究中缺失的数据,以提高 ML/AI 的准备情况
- 批准号:
10842906 - 财政年份:2022
- 资助金额:
$ 123.9万 - 项目类别:
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
转移性去势抵抗性前列腺癌的影像学和基于液体的肿瘤监测生物标志物的临床资格
- 批准号:
9974088 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
转移性去势抵抗性前列腺癌的影像学和基于液体的肿瘤监测生物标志物的临床资格
- 批准号:
10447573 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
转移性去势抵抗性前列腺癌的影像学和基于液体的肿瘤监测生物标志物的临床资格
- 批准号:
10868060 - 财政年份:2020
- 资助金额:
$ 123.9万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 123.9万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 123.9万 - 项目类别:
Standard Grant














{{item.name}}会员




